Ethyl 5-bromo-7-methyl-1-benzofuran-3-carboxylate, 95%, 50mg

2,3-dihydroxybenzoic acid, min. 98%, 5 g, plastic packaging.

4-Bromo-2-(trifluoromethyl)pyridine, 95.0%, 25g

Diethyl 2-(2-cyanoethyl)malonate, 95.0%, 100g

4-Amino-5-bromo-2-fluorobenzonitrile, 98%, 5g

3-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 97.0%, 10g

(4-(Trifluoromethyl)phenyl)methanamine hydrochloride, 95.0%, 250mg

2,3-Bis(methylthio)quinoxaline, 90%, 1g

3-(2-Hydroxyphenyl)propionic acid, 95.0%, 25g

6-(5-((3aS,4S,6aR)-2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)hexanoic acid, 95.0%, 5g

4,4'-Dibromo-2,2'-bipyridine, 95.0%, 10g

3-Methyl-1-(pyridin-2-ylmethyl)-1H-pyrazole-5-carboxylic acid, >95%, 1g

Tert-butyl (4-(2,5-difluorophenyl)-4-oxobutyl)carbamate, 98%, 250mg